Comparative effects of sulphonylureas, dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care.

Wilkinson, Samantha; Williamson, Elizabeth; Pokrajac, Ana; Fogarty, Damian; Stirnadel-Farrant, Heide; Smeeth, Liam; Douglas, Ian J; Tomlinson, Laurie A; (2020) Comparative effects of sulphonylureas, dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care. Diabetes, obesity & metabolism, 22 (5). pp. 847-856. ISSN 1462-8902 DOI: https://doi.org/10.1111/dom.13970

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1111/dom.13970

Abstract

Share

Download

Embargo Date: 18 January 2021

Restricted to: Repository staff only

Filename: Wilkinson_et_al-2020-Diabetes,_Obesity_and_Metabolism.pdf

Licence: Copyright the author(s)

[img]

Downloads

View details

Metrics & Citations


Google Scholar